Cargando…
Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy
The past years have witnessed a rapid increase in the amount of large-scale tumor datasets. The challenge has now become to find a way to obtain useful information from these masses of data that will allow to determine which combination of FDA-approved drugs is best suited to treat the specific tumo...
Autores principales: | Flashner-Abramson, Efrat, Vasudevan, Swetha, Adejumobi, Ibukun Adesoji, Sonnenblick, Amir, Kravchenko-Balasha, Nataly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691586/ https://www.ncbi.nlm.nih.gov/pubmed/31410207 http://dx.doi.org/10.7150/thno.31657 |
Ejemplares similares
-
Exploring Alzheimer’s Disease Molecular Variability via Calculation of Personalized Transcriptional Signatures
por: Dagan, Hila, et al.
Publicado: (2020) -
Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures
por: Vasudevan, Swetha, et al.
Publicado: (2021) -
Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
por: Jubran, Maria R., et al.
Publicado: (2022) -
Overcoming resistance to BRAF(V600E) inhibition in melanoma by deciphering and targeting personalized protein network alterations
por: Vasudevan, S., et al.
Publicado: (2021) -
Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading
por: Jubran, Maria R., et al.
Publicado: (2020)